{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:40:16Z","timestamp":1763415616484,"version":"3.37.3"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10787-022-01120-w","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T17:04:55Z","timestamp":1671642295000},"page":"253-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Perspectives of colon-specific drug delivery in the management of morning symptoms of rheumatoid arthritis"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-5481","authenticated-orcid":false,"given":"Swapnil N.","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8562-8670","authenticated-orcid":false,"given":"Sanjay B.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"1120_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1081\/DDC-120018373","volume":"29","author":"EO Akala","year":"2003","unstructured":"Akala EO, Elekwachi O, Chase V, Johnson H, Lazarre M, Scott K (2003) Organic redox-initiated polymerization process for the fabrication of hydrogels for colon-specific drug delivery. Drug Dev Ind Pharm 29:375\u2013386. https:\/\/doi.org\/10.1081\/DDC-120018373","journal-title":"Drug Dev Ind Pharm"},{"key":"1120_CR2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320:1360\u20131372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA"},{"key":"1120_CR3","unstructured":"Basit A, Bloor J (2003) Perspectives on colonic drug delivery. In: Business briefing: Pharmatech, World Markets Research Centre, pp 185\u2013190."},{"key":"1120_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/gut.29.9.1173","volume":"29","author":"G Bassotti","year":"1988","unstructured":"Bassotti G, Gaburri M, Imbimbo B et al (1988) Colonic mass movements in idiopathic chronic constipation. Gut 29:1173\u20131179. https:\/\/doi.org\/10.1136\/gut.29.9.1173","journal-title":"Gut"},{"key":"1120_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62:1583\u20131591. https:\/\/doi.org\/10.1002\/art.27405","journal-title":"Arthritis Rheum"},{"key":"1120_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000092878","volume":"24","author":"J Bratten","year":"2006","unstructured":"Bratten J, Jones MP (2006) New directions in the assessment of gastric function: clinical applications of physiologic measurements. Dig Dis 24:252\u2013259. https:\/\/doi.org\/10.1159\/000092878","journal-title":"Dig Dis"},{"key":"1120_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1081\/CBI-120037816","volume":"21","author":"RL Brown","year":"2004","unstructured":"Brown RL, Robinson PR (2004) Melanopsin\u2014shedding light on the elusive circadian photopigment. Chronobiol Int 21:189\u2013204. https:\/\/doi.org\/10.1081\/CBI-120037816","journal-title":"Chronobiol Int"},{"key":"1120_CR8","doi-asserted-by":"publisher","first-page":"s142","DOI":"10.1016\/S0753-3322(01)90020-4","volume":"55","author":"N Burioka","year":"2000","unstructured":"Burioka N, Sako T, Tomita K et al (2000) Theophylline chronotherapy of nocturnal asthma using bathyphase of circadian rhythm in peak expiratory flow rate. Biomed Pharmacother 55:s142\u2013s146. https:\/\/doi.org\/10.1016\/S0753-3322(01)90020-4","journal-title":"Biomed Pharmacother"},{"key":"1120_CR9","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. Lancet 389:2338\u20132348. https:\/\/doi.org\/10.1016\/S0140-6736(17)31491-5","journal-title":"Lancet"},{"key":"1120_CR10","doi-asserted-by":"publisher","unstructured":"Buttgereit F, Smolen JS, Coogan AN et al (2015) Clocking in: chronobiology in rheumatoid arthritis. Nature Reviews Rheumatology 11:349\u2013356. https:\/\/doi.org\/10.1038\/nrrheum.2015.31","DOI":"10.1038\/nrrheum.2015.31"},{"key":"1120_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejpb.2015.03.004","volume":"92","author":"T Cerchiara","year":"2015","unstructured":"Cerchiara T, Abruzzo A, Di Cagno M et al (2015) Chitosan based micro-and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods. Eur J Pharm Biopharm 92:112\u2013119. https:\/\/doi.org\/10.1016\/j.ejpb.2015.03.004","journal-title":"Eur J Pharm Biopharm"},{"key":"1120_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fphar.2015.00071","volume":"6","author":"L Chen","year":"2015","unstructured":"Chen L, Yang G (2015) Recent advances in circadian rhythms in cardiovascular system. Front Pharmacol 6:71. https:\/\/doi.org\/10.3389\/fphar.2015.00071","journal-title":"Front Pharmacol"},{"key":"1120_CR13","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s10067-017-3769-4","volume":"36","author":"MS Chimenti","year":"2017","unstructured":"Chimenti MS, Triggianese P, Conigliaro P, Tonelli M, Gigliucci G, Novelli L, Teoli M, Perricone R (2017) A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors. Clin Rheumatol 36:2253\u20132260. https:\/\/doi.org\/10.1007\/s10067-017-3769-4","journal-title":"Clin Rheumatol"},{"key":"1120_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.autrev.2019.05.007","volume":"18","author":"P Conigliaro","year":"2019","unstructured":"Conigliaro P, Triggianese P, De Martino E et al (2019) Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev 18:706\u2013713. https:\/\/doi.org\/10.1016\/j.autrev.2019.05.007","journal-title":"Autoimmun Rev"},{"key":"1120_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41569-019-0167-4","volume":"16","author":"S Crnko","year":"2019","unstructured":"Crnko S, Du Pr\u00e9 BC, Sluijter JP, Van Laake LW (2019) Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nat Rev Cardiol 16:437\u2013447. https:\/\/doi.org\/10.1038\/s41569-019-0167-4","journal-title":"Nat Rev Cardiol"},{"key":"1120_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","volume":"77","author":"CS Crowson","year":"2018","unstructured":"Crowson CS, Rollefstad S, Ikdahl E et al (2018) Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 77:48\u201354. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211735","journal-title":"Ann Rheum Dis"},{"key":"1120_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/ar4687","volume":"7","author":"M Cutolo","year":"2011","unstructured":"Cutolo M (2011) Circadian and circannual rhythms in RA. Nat Rev Rheumatol 7:500\u2013502. https:\/\/doi.org\/10.1186\/ar4687","journal-title":"Nat Rev Rheumatol"},{"key":"1120_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000203","volume":"2","author":"M Cutolo","year":"2016","unstructured":"Cutolo M (2016) Glucocorticoids and chronotherapy in rheumatoid arthritis. RMD Open 2:e000203. https:\/\/doi.org\/10.1136\/rmdopen-2015-000203","journal-title":"RMD Open"},{"key":"1120_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.autrev.2005.04.019","volume":"4","author":"M Cutolo","year":"2005","unstructured":"Cutolo M, Villaggio B, Otsa K et al (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease\u2019s symptoms. Autoimmun Rev 4:497\u2013502. https:\/\/doi.org\/10.1016\/j.autrev.2005.04.019","journal-title":"Autoimmun Rev"},{"key":"1120_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/ncprheum0601","volume":"3","author":"M Cutolo","year":"2007","unstructured":"Cutolo M, Straub RH, Bijlsma JW (2007) Neuroendocrine\u2013immune interactions in synovitis. Nat Clin Pract Rheumatol 3:627\u2013634. https:\/\/doi.org\/10.1038\/ncprheum0601","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1120_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-pharmtox-011613-135923","volume":"54","author":"R Dallmann","year":"2014","unstructured":"Dallmann R, Brown SA, Gachon F (2014) Chronopharmacology: new insights and therapeutic implications. Annu Rev Pharmacol Toxicol 54:339\u2013361. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011613-135923","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1120_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/1529-0131","volume":"43","author":"JC Dekkers","year":"2000","unstructured":"Dekkers JC, Geenen R, Godaert GL et al (2000) Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheumatism 43:465\u2013467. https:\/\/doi.org\/10.1002\/1529-0131","journal-title":"Arthritis Rheumatism"},{"key":"1120_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00281-017-0627-z","volume":"39","author":"V Derksen","year":"2007","unstructured":"Derksen V, Huizinga T, Van Der Woude D (2007) The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol 39:437\u2013446. https:\/\/doi.org\/10.1007\/s00281-017-0627-z","journal-title":"Semin Immunopathol"},{"key":"1120_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/annurev-physiol-021909-135821","volume":"72","author":"C Dibner","year":"2010","unstructured":"Dibner C, Schibler U, Albrecht U (2010) The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 72:517\u2013549. https:\/\/doi.org\/10.1146\/annurev-physiol-021909-135821","journal-title":"Annu Rev Physiol"},{"key":"1120_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2017-018752","volume":"8","author":"KL Druce","year":"2018","unstructured":"Druce KL, Cordingley L, Short V et al (2018) Quality of life, sleep and rheumatoid arthritis (QUASAR): a protocol for a prospective UK mHealth study to investigate the relationship between sleep and quality of life in adults with rheumatoid arthritis. BMJ Open 8:1\u201314. https:\/\/doi.org\/10.1136\/bmjopen-2017-018752","journal-title":"BMJ Open"},{"key":"1120_CR26","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/art.21778","volume":"54","author":"P Emery","year":"2006","unstructured":"Emery P, Fleischmann R, Filipowicz-Sosnowska A et al (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54:1390\u20131400. https:\/\/doi.org\/10.1002\/art.21778","journal-title":"Arthritis Rheum"},{"key":"1120_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biopha.2003.08.012","volume":"57","author":"M Eriguchi","year":"2003","unstructured":"Eriguchi M, Levi F, Hisa T et al (2003) Chronotherapy for cancer. Biomed Pharmacother 57:92\u201395. https:\/\/doi.org\/10.1016\/j.biopha.2003.08.012","journal-title":"Biomed Pharmacother"},{"key":"1120_CR28","doi-asserted-by":"publisher","unstructured":"Evans JA, Davidson AJ (2013) Health consequences of circadian disruption in humans and animal models. In: Progress in molecular biology and translational science, vol 119. Elsevier, pp 283\u2013323. https:\/\/doi.org\/10.1016\/B978-0-12-396971-2.00010-5","DOI":"10.1016\/B978-0-12-396971-2.00010-5"},{"key":"1120_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/1871530317666171114122417","volume":"18","author":"SA Fazal","year":"2018","unstructured":"Fazal SA, Khan M, Nishi SE, Alam F, Zarin N, Bari MT, Ashraf GM (2018) A clinical update and global economic burden of rheumatoid arthritis. Endocrine Metabo Immune Disorders Drug Targets 18:98\u2013109. https:\/\/doi.org\/10.2174\/1871530317666171114122417","journal-title":"Endocrine Metabo Immune Disorders Drug Targets"},{"key":"1120_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10717544.2010.509358","volume":"18","author":"B Gandhi","year":"2011","unstructured":"Gandhi B, Mundada A, Gandhi P (2011) Chronopharmaceutics: as a clinically relevant drug delivery system. Drug Delivery 18:1\u201318. https:\/\/doi.org\/10.3109\/10717544.2010.509358","journal-title":"Drug Delivery"},{"key":"1120_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/imm.12525","volume":"146","author":"SS Geiger","year":"2015","unstructured":"Geiger SS, Fagundes CT, Siegel RM (2015) Chrono-immunology: progress and challenges in understanding links between the circadian and immune systems. Immunology 146:349\u2013358. https:\/\/doi.org\/10.1111\/imm.12525","journal-title":"Immunology"},{"key":"1120_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.survophthal.2004.06.003","volume":"49","author":"D Gherghel","year":"2004","unstructured":"Gherghel D, Hosking SL, Orgul S (2004) Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 49:491\u2013508. https:\/\/doi.org\/10.1016\/j.survophthal.2004.06.003","journal-title":"Surv Ophthalmol"},{"key":"1120_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/ar4146","volume":"15","author":"JE Gibbs","year":"2013","unstructured":"Gibbs JE, Ray DW (2013) The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther 15:205. https:\/\/doi.org\/10.1186\/ar4146","journal-title":"Arthritis Res Ther"},{"key":"1120_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsps.2015.03.001","volume":"24","author":"MA Hadi","year":"2016","unstructured":"Hadi MA, Rao NR, Rao AS (2016) Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of naproxen for chronotherapeutic treatment of rheumatoid arthritis. Saudi Pharmaceut J 24:64\u201373. https:\/\/doi.org\/10.1016\/j.jsps.2015.03.001","journal-title":"Saudi Pharmaceut J"},{"key":"1120_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/bmj.284.6315.551","volume":"284","author":"J Harkness","year":"1982","unstructured":"Harkness J, Richter M, Panayi G et al (1982) Circadian variation in disease activity in rheumatoid arthritis. Br Med J (clin Res Ed) 284:551\u2013554. https:\/\/doi.org\/10.1136\/bmj.284.6315.551","journal-title":"Br Med J (clin Res Ed)"},{"key":"1120_CR36","doi-asserted-by":"publisher","first-page":"12527","DOI":"10.1073\/pnas.0804340105","volume":"105","author":"NG Hatcher","year":"2008","unstructured":"Hatcher NG, Atkins N Jr, Annangudi SP et al (2008) Mass spectrometry-based discovery of circadian peptides. Proc Natl Acad Sci USA 105:12527\u201312532. https:\/\/doi.org\/10.1073\/pnas.0804340105","journal-title":"Proc Natl Acad Sci USA"},{"key":"1120_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.addr.2007.01.001","volume":"59","author":"E Haus","year":"2007","unstructured":"Haus E (2007) Chronobiology in the endocrine system. Adv Drug Deliv Rev 59:985\u20131014. https:\/\/doi.org\/10.1016\/j.addr.2007.01.001","journal-title":"Adv Drug Deliv Rev"},{"key":"1120_CR38","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","volume":"11","author":"S Hua","year":"2015","unstructured":"Hua S, Marks E, Schneider JJ, Keely S (2015) Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine 11:1117\u20131132. https:\/\/doi.org\/10.1016\/j.nano.2015.02.018","journal-title":"Nanomedicine"},{"key":"1120_CR39","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1007\/s11095-008-9580-9","volume":"25","author":"VC Ibekwe","year":"2008","unstructured":"Ibekwe VC, Fadda HM, McConnell EL et al (2008) Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems. Pharm Res 25:1828\u20131835. https:\/\/doi.org\/10.1007\/s11095-008-9580-9","journal-title":"Pharm Res"},{"key":"1120_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clim.2018.04.008","volume":"192","author":"M Iris","year":"2018","unstructured":"Iris M, Tsou PS, Sawalha AH (2018) Caffeine inhibits STAT1 signaling and downregulates inflammatory pathways involved in autoimmunity. Clin Immunol 192:68\u201377. https:\/\/doi.org\/10.1016\/j.clim.2018.04.008","journal-title":"Clin Immunol"},{"key":"1120_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1365-2036.2000.00697.x","volume":"14","author":"H Ja","year":"2000","unstructured":"Ja H, Blackshaw P, Perkins A, Wilson C, Spiller R (2000) Limited exposure of the healthy distal colon to orally-dosed formulation is further exaggerated in active left-sided ulcerative colitis. Aliment Pharmacol Ther 14:155\u2013162","journal-title":"Aliment Pharmacol Ther"},{"key":"1120_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0168-3659(01)00211-5","volume":"71","author":"Y-I Jeong","year":"2001","unstructured":"Jeong Y-I, Ohno T, Hu Z et al (2001) Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method. J Control Release 71:175\u2013182. https:\/\/doi.org\/10.1016\/S0168-3659(01)00211-5","journal-title":"J Control Release"},{"key":"1120_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/2230-973X.147232","volume":"5","author":"R Kadiyam","year":"2015","unstructured":"Kadiyam R, Muzib YI (2015) Colon specific drug delivery of tramadol HCl for chronotherapeutics of arthritis. Int J Pharmaceut Investig 5:43. https:\/\/doi.org\/10.4103\/2230-973X.147232","journal-title":"Int J Pharmaceut Investig"},{"key":"1120_CR44","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3109\/10837450902922736","volume":"14","author":"Z Khan","year":"2009","unstructured":"Khan Z, Pillay V, Choonara YE et al (2009) Drug delivery technologies for chronotherapeutic applications. Pharm Dev Technol 14:602\u2013612. https:\/\/doi.org\/10.3109\/10837450902922736","journal-title":"Pharm Dev Technol"},{"key":"1120_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.mpmed.2018.01.006","volume":"46","author":"PD Kiely","year":"2018","unstructured":"Kiely PD, Nikiphorou E (2018) Management of rheumatoid arthritis. Medicine 46:216\u2013221. https:\/\/doi.org\/10.1016\/j.mpmed.2018.01.006","journal-title":"Medicine"},{"key":"1120_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA\u2013DR (shared epitope)\u2013restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheumatism 54:38\u201346. https:\/\/doi.org\/10.1002\/art.21575","journal-title":"Arthritis Rheumatism"},{"key":"1120_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jconrel.2008.06.014","volume":"130","author":"S Klein","year":"2008","unstructured":"Klein S, Rudolph MW, Skalsky B, Petereit H-U, Dressman JB (2008) Use of the BioDis to generate a physiologically relevant IVIVC. J Control Release 130:216\u2013219. https:\/\/doi.org\/10.1016\/j.jconrel.2008.06.014","journal-title":"J Control Release"},{"key":"1120_CR48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.colsurfb.2016.10.049","volume":"150","author":"B Kumar","year":"2017","unstructured":"Kumar B, Kulanthaivel S, Mondal A et al (2017) Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping. Colloids Surf B 150:352\u2013361. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.10.049","journal-title":"Colloids Surf B"},{"key":"1120_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.addr.2013.10.001","volume":"71","author":"C Lautenschl\u00e4ger","year":"2014","unstructured":"Lautenschl\u00e4ger C, Schmidt C, Fischer D, Stallmach A (2014) Drug delivery strategies in the therapy of inflammatory bowel disease. Adv Drug Deliv Rev 71:58\u201376. https:\/\/doi.org\/10.1016\/j.addr.2013.10.001","journal-title":"Adv Drug Deliv Rev"},{"key":"1120_CR50","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2353\/ajpath.2008.070703","volume":"172","author":"MC Lebre","year":"2008","unstructured":"Lebre MC, Jongbloed SL, Tas SW et al (2008) Rheumatoid arthritis synovium contains two subsets of CD83\u2212 DC-LAMP\u2212 dendritic cells with distinct cytokine profiles. Am J Pathol 172:940\u2013950. https:\/\/doi.org\/10.2353\/ajpath.2008.070703","journal-title":"Am J Pathol"},{"key":"1120_CR51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2011.09.065","volume":"157","author":"S-Y Lin","year":"2012","unstructured":"Lin S-Y, Kawashima Y (2012) Current status and approaches to developing press-coated chronodelivery drug systems. J Control Release 157:331\u2013353. https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.065","journal-title":"J Control Release"},{"key":"1120_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.0269-2813.2004.01827.x","volume":"19","author":"E Loftus Jr","year":"2004","unstructured":"Loftus E Jr, Kane S, Bjorkman D (2004) Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther 19:179\u2013189. https:\/\/doi.org\/10.1111\/j.0269-2813.2004.01827.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1120_CR53","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3109\/03639041003786185","volume":"36","author":"V Lotlikar","year":"2010","unstructured":"Lotlikar V, Kedar U, Shidhaye S, Kadam V (2010) pH-responsive dual pulse multiparticulate dosage form for treatment of rheumatoid arthritis. Drug Dev Ind Pharm 36:1295\u20131302. https:\/\/doi.org\/10.3109\/03639041003786185","journal-title":"Drug Dev Ind Pharm"},{"key":"1120_CR54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejpb.2008.12.002","volume":"72","author":"A Maroni","year":"2009","unstructured":"Maroni A, Del Curto MD, Serratoni M, Zema L, Foppoli A, Gazzaniga A, Sangalli ME (2009) Feasibility, stability and release performance of a time-dependent insulin delivery system intended for oral colon release. Eur J Pharm Biopharm 72:246\u2013251. https:\/\/doi.org\/10.1016\/j.ejpb.2008.12.002","journal-title":"Eur J Pharm Biopharm"},{"key":"1120_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","volume":"364","author":"EL McConnell","year":"2008","unstructured":"McConnell EL, Fadda HM, Basit AW (2008) Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 364:213\u2013226. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.05.012","journal-title":"Int J Pharm"},{"key":"1120_CR56","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219. https:\/\/doi.org\/10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"key":"1120_CR57","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/pharmaceutics13050759","volume":"13","author":"A Melocchi","year":"2021","unstructured":"Melocchi A, Uboldi M, Briatico-Vangosa F, Moutaharrik S, Cerea M, Foppoli A, Maroni A, Palugan L, Zema L, Gazzaniga A (2021) The chronotopic\u2122 system for pulsatile and colonic delivery of active molecules in the era of precision medicine: feasibility by 3D printing via fused deposition modeling (FDM). Pharmaceutics 13:759. https:\/\/doi.org\/10.3390\/pharmaceutics13050759","journal-title":"Pharmaceutics"},{"key":"1120_CR58","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.2147\/DDDT.S88672","volume":"9","author":"M Naeem","year":"2015","unstructured":"Naeem M, Choi M, Cao J et al (2015) Colon-targeted delivery of budesonide using dual pH-and time-dependent polymeric nanoparticles for colitis therapy. Drug Des Dev Ther 9:3789. https:\/\/doi.org\/10.2147\/DDDT.S88672","journal-title":"Drug Des Dev Ther"},{"key":"1120_CR59","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.48.4.571","volume":"48","author":"S Nugent","year":"2001","unstructured":"Nugent S, Kumar D, Rampton D, Evans D (2001) Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 48:571\u2013577. https:\/\/doi.org\/10.1136\/gut.48.4.571","journal-title":"Gut"},{"key":"1120_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/ncprheum0094","volume":"2","author":"GS Panayi","year":"2006","unstructured":"Panayi GS (2006) Even though T-cell-directed trials have been of limited success, is there reason for optimism? Nat Clin Pract Rheumatol 2:58\u201359. https:\/\/doi.org\/10.1038\/ncprheum0094","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1120_CR61","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1126\/science.aah4967","volume":"354","author":"S Panda","year":"2016","unstructured":"Panda S (2016) Circadian physiology of metabolism. Science 354:1008\u20131015. https:\/\/doi.org\/10.1126\/science.aah4967","journal-title":"Science"},{"key":"1120_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2009.10.003","volume":"62","author":"JH Park","year":"2010","unstructured":"Park JH, Saravanakumar G, Kim K, Kwon IC (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 62:28\u201341. https:\/\/doi.org\/10.1016\/j.addr.2009.10.003","journal-title":"Adv Drug Deliv Rev"},{"key":"1120_CR63","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1517\/17425247.2011.597739","volume":"8","author":"MM Patel","year":"2011","unstructured":"Patel MM (2011) Cutting-edge technologies in colon-targeted drug delivery systems. Expert Opin Drug Deliv 8:1247\u20131258. https:\/\/doi.org\/10.1517\/17425247.2011.597739","journal-title":"Expert Opin Drug Deliv"},{"key":"1120_CR64","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1517\/17425247.2014.927440","volume":"11","author":"MM Patel","year":"2014","unstructured":"Patel MM (2014) Getting into the colon: approaches to target colorectal cancer. Expert Opin Drug Deliv 11:1343\u20131350. https:\/\/doi.org\/10.1517\/17425247.2014.927440","journal-title":"Expert Opin Drug Deliv"},{"key":"1120_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/ard.2007.086561","volume":"68","author":"MG Perry","year":"2009","unstructured":"Perry MG, Kirwan J, Jessop D, Hunt L (2009) Overnight variations in cortisol, interleukin 6, tumour necrosis factor \u03b1 and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 68:63\u201368","journal-title":"Ann Rheum Dis"},{"key":"1120_CR66","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.autrev.2018.06.007","volume":"17","author":"S Petersson","year":"2018","unstructured":"Petersson S, Philippou E, Rodomar C et al (2018) The Mediterranean diet, fish oil supplements and rheumatoid arthritis outcomes: evidence from clinical trials. Autoimmun Rev 17:1105\u20131114. https:\/\/doi.org\/10.1016\/j.autrev.2018.06.007","journal-title":"Autoimmun Rev"},{"key":"1120_CR67","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.autrev.2018.05.009","volume":"17","author":"E Philippou","year":"2018","unstructured":"Philippou E, Nikiphorou E (2018) Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis. Autoimmun Rev 17:1074\u20131077. https:\/\/doi.org\/10.1016\/j.autrev.2018.05.009","journal-title":"Autoimmun Rev"},{"key":"1120_CR68","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0169-409X(98)00040-4","volume":"34","author":"G Ponchel","year":"1998","unstructured":"Ponchel G, Irache J-M (1998) Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 34:191\u2013219. https:\/\/doi.org\/10.1016\/S0169-409X(98)00040-4","journal-title":"Adv Drug Deliv Rev"},{"key":"1120_CR69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1166\/jbn.2009.1038","volume":"5","author":"D Prajakta","year":"2009","unstructured":"Prajakta D, Ratnesh J, Chandan K, Suresh S, Grace S, Meera V, Vandana P (2009) Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J Biomed Nanotechnol 5:445\u2013455. https:\/\/doi.org\/10.1166\/jbn.2009.1038","journal-title":"J Biomed Nanotechnol"},{"key":"1120_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/10717544.2012.762434","volume":"20","author":"T Ramasamy","year":"2013","unstructured":"Ramasamy T, Ruttala HB, Shanmugam S et al (2013) Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis. Drug Delivery 20:65\u201377. https:\/\/doi.org\/10.3109\/10717544.2012.762434","journal-title":"Drug Delivery"},{"key":"1120_CR71","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/bjsm.2003.006825","volume":"38","author":"K Rao","year":"2004","unstructured":"Rao K, Yazaki E, Evans D, Carbon R (2004) Objective evaluation of small bowel and colonic transit time using pH telemetry in athletes with gastrointestinal symptoms. Br J Sports Med 38:482\u2013487. https:\/\/doi.org\/10.1136\/bjsm.2003.006825","journal-title":"Br J Sports Med"},{"key":"1120_CR72","doi-asserted-by":"publisher","first-page":"R432","DOI":"10.1016\/j.cub.2016.04.011","volume":"26","author":"T Roenneberg","year":"2016","unstructured":"Roenneberg T, Merrow M (2016) The circadian clock and human health. Curr Biol 26:R432\u2013R443. https:\/\/doi.org\/10.1016\/j.cub.2016.04.011","journal-title":"Curr Biol"},{"key":"1120_CR73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","volume":"74","author":"Y Rombouts","year":"2015","unstructured":"Rombouts Y, Ewing E, van de Stadt LA et al (2015) Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis 74:234\u2013241. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203565","journal-title":"Ann Rheum Dis"},{"key":"1120_CR74","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1136\/annrheumdis-2018-213687","volume":"77","author":"NM Roodenrijs","year":"2018","unstructured":"Roodenrijs NM, de Hair MJ, van der Goes MC, Jacobs JW, Welsing PM, van der Heijde D, Aletaha D, Dougados M, Hyrich KL, McInnes IB (2018) Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey. Ann Rheum Dis 77:1705\u20131709. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213687","journal-title":"Ann Rheum Dis"},{"key":"1120_CR75","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3109\/02652048.2015.1081417","volume":"32","author":"K Sanka","year":"2015","unstructured":"Sanka K, Pragada RR, Veerareddy PR (2015) A pH-triggered delayed-release chronotherapeutic drug delivery system of aceclofenac for effective management of early morning symptoms of rheumatoid arthritis. J Microencapsul 32:794\u2013803. https:\/\/doi.org\/10.3109\/02652048.2015.1081417","journal-title":"J Microencapsul"},{"key":"1120_CR76","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1084\/jem.20131241","volume":"210","author":"SW Scally","year":"2013","unstructured":"Scally SW, Petersen J, Law SC et al (2013) A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med 210:2569\u20132582. https:\/\/doi.org\/10.1084\/jem.20131241","journal-title":"J Exp Med"},{"key":"1120_CR77","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nri3386","volume":"13","author":"C Scheiermann","year":"2013","unstructured":"Scheiermann C, Kunisaki Y, Frenette PS (2013) Circadian control of the immune system. Nat Rev Immunol 13:190\u2013198. https:\/\/doi.org\/10.1038\/nri3386","journal-title":"Nat Rev Immunol"},{"key":"1120_CR78","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.3260","volume":"19","author":"G Schett","year":"2013","unstructured":"Schett G, Elewaut D, McInnes IB et al (2013) How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy. Nat Med 19:822\u2013824. https:\/\/doi.org\/10.1038\/nm.3260","journal-title":"Nat Med"},{"key":"1120_CR79","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0024-3205(99)00103-4","volume":"64","author":"A Schmidt-Reinwald","year":"1999","unstructured":"Schmidt-Reinwald A, Pruessner J, Hellhammer D, Federenko I, Rohleder N, Sch\u00fcrmeyer T, Kirschbaum C (1999) The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci 64:1653\u20131660. https:\/\/doi.org\/10.1016\/S0024-3205(99)00103-4","journal-title":"Life Sci"},{"key":"1120_CR80","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41575-020-00401-5","volume":"18","author":"A Segers","year":"2021","unstructured":"Segers A, Depoortere I (2021) Circadian clocks in the digestive system. Nat Rev Gastroenterol Hepatol 18:239\u2013251. https:\/\/doi.org\/10.1038\/s41575-020-00401-5","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1120_CR81","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/sj.bjc.6603033","volume":"94","author":"P Simmonds","year":"2006","unstructured":"Simmonds P, Primrose J, Colquitt J et al (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982\u2013999. https:\/\/doi.org\/10.1038\/sj.bjc.6603033","journal-title":"Br J Cancer"},{"key":"1120_CR82","first-page":"34","volume":"33","author":"CM Spies","year":"2015","unstructured":"Spies CM, Hoff P, Mazuch J et al (2015) Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study. Clin Exp Rheumatol 33:34\u201343","journal-title":"Clin Exp Rheumatol"},{"key":"1120_CR83","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/art.22368","volume":"56","author":"RH Straub","year":"2007","unstructured":"Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheumatism 56:399\u2013408. https:\/\/doi.org\/10.1002\/art.22368","journal-title":"Arthritis Rheumatism"},{"key":"1120_CR84","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1073\/pnas.090636110","volume":"116","author":"ER Sutherland","year":"2005","unstructured":"Sutherland ER (2005) Nocturnal asthma. J Allergy Clin Immunol 116:1179\u20131186. https:\/\/doi.org\/10.1073\/pnas.090636110","journal-title":"J Allergy Clin Immunol"},{"key":"1120_CR85","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/10611869708995842","volume":"4","author":"T Takaya","year":"1997","unstructured":"Takaya T, Sawada K, Suzuki H, Funaoka A, Matsuda K-I, Takada K (1997) Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs. J Drug Target 4:271\u2013276. https:\/\/doi.org\/10.3109\/10611869708995842","journal-title":"J Drug Target"},{"key":"1120_CR86","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ejps.2013.04.031","volume":"49","author":"F Talaei","year":"2013","unstructured":"Talaei F, Atyabi F, Azhdarzadeh M, Dinarvand R, Saadatzadeh A (2013) Overcoming therapeutic obstacles in inflammatory bowel diseases: a comprehensive review on novel drug delivery strategies. Eur J Pharm Sci 49:712\u2013722. https:\/\/doi.org\/10.1016\/j.ejps.2013.04.031","journal-title":"Eur J Pharm Sci"},{"key":"1120_CR87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1021\/mp800261a","volume":"6","author":"C Tannergren","year":"2009","unstructured":"Tannergren C, Bergendal A, Lennernas H, Abrahamsson B (2009) Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. Mol Pharm 6:60\u201373. https:\/\/doi.org\/10.1021\/mp800261a","journal-title":"Mol Pharm"},{"key":"1120_CR88","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/s0002-9394(02)01459-9","volume":"133","author":"MB Wax","year":"2002","unstructured":"Wax MB, Camras CB, Fiscella RG et al (2002) Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure. Am J Ophthalmol 133:S1-10. https:\/\/doi.org\/10.1016\/s0002-9394(02)01459-9","journal-title":"Am J Ophthalmol"},{"key":"1120_CR89","doi-asserted-by":"publisher","unstructured":"Wijbrandts C, Tak P Prediction of response to targeted treatment in rheumatoid arthritis. In: Mayo Clinic Proceedings, 2017. Elsevier, 7:1129\u20131143. https:\/\/doi.org\/10.1016\/j.mayocp.2017.05.009","DOI":"10.1016\/j.mayocp.2017.05.009"},{"key":"1120_CR90","first-page":"613","volume":"102","author":"J-M Wong","year":"2003","unstructured":"Wong J-M, Wei S-C (2003) Efficacy of Pentasa tablets for the treatment of inflammatory bowel disease. J Formos Med Assoc 102:613\u2013619","journal-title":"J Formos Med Assoc"},{"key":"1120_CR91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2004.05.015","volume":"98","author":"BB Youan","year":"2004","unstructured":"Youan BB (2004) Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Controlled Release 98:337\u2013353. https:\/\/doi.org\/10.1016\/j.jconrel.2004.05.015","journal-title":"J Controlled Release"},{"key":"1120_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.10.003","volume":"65","author":"E Zampeli","year":"2015","unstructured":"Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG (2015) Treatment of rheumatoid arthritis: unraveling the conundrum. J Autoimmun 65:1\u201318. https:\/\/doi.org\/10.1016\/j.jaut.2015.10.003","journal-title":"J Autoimmun"},{"key":"1120_CR93","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/1061186X.2015.1128941","volume":"24","author":"L Zhang","year":"2016","unstructured":"Zhang L, Sang Y, Feng J et al (2016) Polysaccharide-based micro\/nanocarriers for oral colon-targeted drug delivery. J Drug Target 24:579\u2013589. https:\/\/doi.org\/10.3109\/1061186X.2015.1128941","journal-title":"J Drug Target"},{"key":"1120_CR94","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1081\/CBI-100101056","volume":"17","author":"M Zordan","year":"2000","unstructured":"Zordan M, Costa R, Macino G et al (2000) Circadian clocks: what makes them tick? Chronobiol Int 17:433\u2013451. https:\/\/doi.org\/10.1081\/CBI-100101056","journal-title":"Chronobiol Int"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01120-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01120-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01120-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T09:41:21Z","timestamp":1677231681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01120-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1120"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01120-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}